Results from our previous studies suggest that LD-IL-2 treatment increases the number/function of immunosuppressive Treg cells in dura and TG, thereby reversing chronic headache-related sensitization, including repeated sumatriptan-induced facial skin hypersensitivity [12, 20]. This evidence concerns the gene IL2 and headache disorder.